Cecelia Calhoun, MD, MSPH, MBA, has been appointed Assistant Professor of Medicine (Hematology) and Assistant Professor of Pediatrics (Hematology/Oncology) at Yale Cancer Center and Smilow Cancer Hospital. Calhoun will care for adolescents and young adults with Sickle Cell Disease as part of the Smilow Cancer Hospital Pediatric and Adult Hematology Programs and serve as Director of the Adolescent-Young Adult Sickle Cell Program.
“We’re very excited to welcome Dr. Calhoun as part of our pediatric and adult Hematology clinical care teams,” said Stephanie Halene, MD, PhD, Associate Professor of Medicine (Hematology), Chief of Hematology at Yale Cancer Center and Smilow Cancer Hospital. “Dr. Calhoun will focus her research efforts on the relationship between health literacy, self-management, and cognition in adolescent and young adult patients with Sickle Cell Disease.” In addition, Calhoun will conduct health services research to better inform interventions and help improve transitions of care for adolescents and young adults with Sickle Cell Disease to adult care.
Calhoun joins Yale Cancer Center and Smilow Cancer Hospital from Washington University School of Medicine where she is an Assistant Professor in Pediatrics, Hematology and Oncology, and Director of the Pediatric Sickle Cell Disease Transition Program. She received her medical degree from Wayne State University and completed her clinical fellowship at Washington University School of Medicine, where she also received her Master of Science in Public Health (MSPH). Calhoun received her Master of Business Administration (MBA) from the Yale University School of Management. In 2019, Calhoun received the Pozen-Commonwealth Fund Fellowship in Minority Health Leadership at Yale, which gives healthcare practitioners the leadership skills and the deep understanding of teams, markets, and organizations necessary to tackle major inequities in the U.S. healthcare system.
Calhoun will start in her new position on July 1, 2021.
About Yale Cancer Center and Smilow Cancer Hospital Yale Cancer Center (YCC) is one of only 51 National Cancer Institute-designated comprehensive cancer centers in the nation and the only such center in Connecticut. Cancer treatment for patients is available at Smilow Cancer Hospital through 13 multidisciplinary teams and at 15 Smilow Cancer Hospital Care Centers in Connecticut and Rhode Island. Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment.
# # #
